Business Context and Reporting Period
Company: U.S. Physical Therapy, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2001
Business Overview: The Company operates 142 outpatient physical and occupational therapy clinics across 30 states, providing post-operative care and treatment for orthopedic and sports-related injuries. It also manages seven third-party facilities. The Company discontinued its surgery center initiative in March 2000.
Key Financial Metrics
| Metric (in thousands) | Q1 2001 | Q1 2000 |
|---|---|---|
| Net Revenues | $18,930 | $14,822 |
| Net Income | $1,512 | $671 |
| Operating Income | $3,814 | $2,108 |
| Cash from Operations | $2,956 | $1,669 |
| Cash and Equivalents (End of Period) | $3,531 | $4,397 |
| Convertible Subordinated Debt | $3,000 | $7,200 |
| Basic EPS | $0.23 | $0.10 |
| Diluted EPS | $0.18 | $0.10 |
Liquidity: Current ratio improved to 5.20:1 from 4.14:1. Debt-to-equity ratio decreased significantly to 0.19:1 from 0.85:1.
Material Changes vs. Prior Period
- Revenue Growth: Net patient revenues increased 29% to $18.3 million, driven by 24 new clinics (43% of growth) and a 12% increase in patient visits at mature clinics.
- Profitability: Net income more than doubled to $1.5 million. Operating margins improved as clinic operating costs as a percentage of revenue decreased from 72% to 69%.
- Debt Reduction: The Company repaid a $900,000 bank loan and converted $4.2 million of convertible subordinated debt into common stock, reducing interest expense by 54%.
- Cost Management: Recruitment and development costs dropped 42% to $369,000, largely due to the exclusion of $301,000 in costs related to the discontinued surgery center initiative in the prior year.
Guidance, Outlook, and Risks
- Expansion Goals: Management aims to open between 30 and 35 new clinics in 2001. New clinics are expected to incur initial operating losses before becoming profitable over 2-3 years.
- Capital Resources: Management believes existing cash and operating cash flows are sufficient to meet needs through 2002. The Company has an unused $500,000 revolving line of credit.
- Accounting Changes: Adopted SFAS 133 regarding derivative instruments; no material effect on financial condition.
- Risks: Forward-looking statements are subject to risks including regulatory changes, competition, and the ability to identify suitable locations and partners for new clinics.
Investor Verification Checklist
- Debt Conversion Impact: Verify the dilution effect of converting $4.2 million of debt into 798,000 shares of common stock.
- New Clinic Performance: Monitor the ramp-up period and profitability timeline for the 24 clinics opened since Q1 2000.
- Receivables Management: Review the increase in patient accounts receivable ($1.5 million increase in cash flow usage) and the provision for doubtful accounts.
- Minority Interests: Note that minority interests in subsidiary partnerships increased 55% to $1.26 million, reflecting higher profitability in partner-owned clinics.